Prevoznik Michael's Insider Trades & SAST Disclosures
Prevoznik Michael's most recent trade in Quest Diagnostics, Inc. was a trade of 4,643 Common Stock done at an average price of $170 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Prevoznik Michael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 170.00 per share. | 17 Mar 2025 | 4,643 | 38,117 (0%) | 0% | 170 | 789,310 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 03 Mar 2025 | 8,549 | 46,666 (0%) | 0% | 173.7 | 1,485,303 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 3,906 | 42,760 (0%) | 0% | 173.7 | 678,628 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 175.79 per share. | 03 Mar 2025 | 592 | 38,117 (0%) | 0% | 175.8 | 104,068 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 322 | 38,709 (0%) | 0% | 173.7 | 55,944 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 172.61 per share. | 26 Feb 2025 | 528 | 39,031 (0%) | 0% | 172.6 | 91,138 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 286 | 39,559 (0%) | 0% | 171.8 | 49,121 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 170.99 per share. | 19 Feb 2025 | 604 | 39,845 (0%) | 0% | 171.0 | 103,278 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 169.71 per share. | 19 Feb 2025 | 374 | 40,449 (0%) | 0% | 169.7 | 63,472 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 8,991 | 8,991 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,345 | 40,823 (0%) | 0% | 0 | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 238,551 | 238,551 | - | - | Stock Options (Right to Buy) | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 45,439 | 527,912 | - | - | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.28 per share. | 12 Dec 2024 | 30,276 | 482,473 | - | 3.3 | 99,305 | Common Stock |
| BTCS Inc | Michael Prevoznik | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.28 per share. | 12 Dec 2024 | 12,223 | 512,749 | - | 3.3 | 40,091 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 35,146 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 29 Nov 2024 | 35,146 | 73,624 (0%) | 0% | 86.6 | 3,044,698 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 163.15 per share. | 29 Nov 2024 | 32,137 | 38,478 (0%) | 0% | 163.1 | 5,243,065 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 162.26 per share. | 29 Nov 2024 | 3,009 | 70,615 (0%) | 0% | 162.3 | 488,237 | Common Stock |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 1.08 per share. | 13 Sep 2024 | 47,397 | 524,972 | - | 1.1 | 51,189 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 154.97 per share. | 29 Aug 2024 | 32,551 | 38,478 (0%) | 0% | 155.0 | 5,044,516 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 32,551 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 29 Aug 2024 | 32,551 | 71,029 (0%) | 0% | 95.8 | 3,118,223 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 125.88 per share. | 28 Feb 2024 | 5,611 | 38,478 (0%) | 0% | 125.9 | 706,313 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 456 | 44,089 (0%) | 0% | 126.4 | 57,620 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 405 | 44,545 (0%) | 0% | 126.4 | 51,176 | Common Stock |
| Quest Diagnostics, Inc. | Prevoznik Michael E. | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 125.02 per share. | 23 Feb 2024 | 7,569 | 47,775 (0%) | 0% | 125.0 | 946,276 | Common Stock |
| Quest Diagnostics, Inc. | Michael Prevoznik E. | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 23 Feb 2024 | 2,825 | 44,950 (0%) | 0% | 125.0 | 353,182 | Common Stock |
| Quest Diagnostics, Inc. | Prevoznik E. Michael | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 126.14 per share. | 21 Feb 2024 | 661 | 40,206 (0%) | 0% | 126.1 | 83,379 | Common Stock |
| Quest Diagnostics, Inc. | Prevoznik E. Michael | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 21 Feb 2024 | 407 | 40,867 (0%) | 0% | 125.0 | 50,883 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 12,231 | 12,231 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael Prevoznik E. | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,935 | 41,274 (0%) | 0% | 0 | Common Stock | |
| BTCS Inc | Prevoznik Michael | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 471,486 | - | - | Common Stock | |
| BTCS Inc | Prevoznik Michael | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,208 | 385,172 | - | - | Common Stock | |
| BTCS Inc | Prevoznik Michael | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 50,000 | 421,486 | - | - | Common Stock | |
| BTCS Inc | Prevoznik Michael | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2024 | 13,686 | 371,486 | - | - | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2024 | 8,481 | 322,964 | - | - | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2023 | 188 | 38,339 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 8,595 | 47,122 (0%) | 0% | 147.9 | 1,270,857 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 140.55 per share. | 06 Mar 2023 | 4,754 | 38,527 (0%) | 0% | 140.6 | 668,175 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 3,841 | 43,281 (0%) | 0% | 147.9 | 567,930 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 138.54 per share. | 01 Mar 2023 | 593 | 38,527 (0%) | 0% | 138.5 | 82,154 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 320 | 39,120 (0%) | 0% | 140.7 | 45,021 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 9,653 | 9,653 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,442 | 40,855 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 141.42 per share. | 23 Feb 2023 | 1,415 | 39,440 (0%) | 0% | 141.4 | 200,109 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 811 | 38,413 (0%) | 0% | 147.9 | 119,914 | Common Stock |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 71,429 | 100,792 | - | - | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 25,000 | 109,221 | - | - | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jan 2023 | 16,571 | 84,221 | - | - | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 23,490 | 29,363 | - | 0 | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 5,873 | 5,873 | - | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.51 per share. | 17 May 2022 | 50,604 | 89,828 (0%) | 0% | 66.5 | 3,365,672 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 50,604 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 139.97 per share. | 17 May 2022 | 50,604 | 39,224 (0%) | 0% | 140.0 | 7,082,991 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 130.09 per share. | 07 Mar 2022 | 11,544 | 50,768 (0%) | 0% | 130.1 | 1,501,759 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 135.21 per share. | 07 Mar 2022 | 6,228 | 39,224 (0%) | 0% | 135.2 | 842,088 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 07 Mar 2022 | 5,316 | 45,452 (0%) | 0% | 130.1 | 691,558 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 28 Feb 2022 | 661 | 39,224 (0%) | 0% | 130 | 85,930 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 13,301 | 13,301 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,741 | 39,885 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 126.26 per share. | 24 Feb 2022 | 1,669 | 37,144 (0%) | 0% | 126.3 | 210,728 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 23 Feb 2022 | 933 | 39,219 (0%) | 0% | 130.1 | 121,374 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.23 per share. | 23 Feb 2022 | 406 | 38,813 (0%) | 0% | 130.2 | 52,873 | Common Stock |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2022 | 55,556 | 55,556 | - | 0 | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2022 | 55,556 | 222,224 | - | 0 | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2022 | 55,556 | 166,668 | - | 0 | Common Stock | |
| BTCS Inc | Michael Prevoznik | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2022 | 55,556 | 111,112 | - | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 137.00 per share. | 05 May 2021 | 44,939 | 40,152 (0%) | 0% | 137 | 6,156,643 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 44,939 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.17 per share. | 05 May 2021 | 44,939 | 85,091 (0%) | 0% | 71.2 | 3,198,309 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 115.42 per share. | 09 Mar 2021 | 9,791 | 49,943 (0%) | 0% | 115.4 | 1,130,077 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 120.47 per share. | 09 Mar 2021 | 5,574 | 40,152 (0%) | 0% | 120.5 | 671,500 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.42 per share. | 09 Mar 2021 | 4,217 | 45,726 (0%) | 0% | 115.4 | 486,726 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 115.49 per share. | 25 Feb 2021 | 801 | 40,152 (0%) | 0% | 115.5 | 92,507 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 116.95 per share. | 23 Feb 2021 | 750 | 40,953 (0%) | 0% | 117.0 | 87,713 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.15 per share. | 23 Feb 2021 | 693 | 42,596 (0%) | 0% | 121.2 | 83,957 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.19 per share. | 23 Feb 2021 | 455 | 42,141 (0%) | 0% | 121.2 | 55,141 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 116.95 per share. | 23 Feb 2021 | 438 | 41,703 (0%) | 0% | 116.9 | 51,224 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 17,958 | 17,958 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,202 | 43,289 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 119.00 per share. | 14 Oct 2020 | 35,591 | 40,087 (0%) | 0% | 119 | 4,235,329 | Common Stock |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2020 | 35,591 | 0 | - | - | Stock Options (Right to Buy) | |
| Quest Diagnostics, Inc. | Michael E. Prevoznik | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.17 per share. | 14 Oct 2020 | 35,591 | 75,678 (0%) | 0% | 52.2 | 1,856,605 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges